Frank Fontaine

University of Queensland — Australia

Biochemistry, Genetics and Molecular Biology · Life Sciences

22h-index1.6kcitations43works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Genomics and Chromatin Dynamics(4), Vascular Malformations and Hemangiomas(4), Alcohol Consumption and Health Effects(4), Marine Sponges and Natural Products(4), Chemical synthesis and alkaloids(4)

Publications43 total

Correction: Pharmacological targeting of the transcription factor SOX18 delays breast cancer in mice
eLife·2023· 1 citedOpen Access
Evolutionary Landscape of SOX Genes to Inform Genotype-to-Phenotype Relationships
Genes·2023· 9 citedOpen Access
Die Vaskulogenese des infantilen Hämangioms kann durch Propranolol und Atenolol ohne Wirkung an Betarezeptoren gehemmt werden
Laryngo-Rhino-Otologie·2022Open Access
Non-β-Blocker Enantiomers of Propranolol and Atenolol Inhibit Vasculogenesis in Infantile Hemangioma
Laryngo-Rhino-Otologie·2022· 1 citedOpen Access
Non–beta blocker enantiomers of propranolol and atenolol inhibit vasculogenesis in infantile hemangioma
Journal of Clinical Investigation·2021· 60 citedOpen Access
A dominant-negative SOX18 mutant disrupts multiple regulatory layers essential to transcription factor activity
Nucleic Acids Research·2021· 20 citedOpen Access
A dominant-negative SOX18 mutant disrupts multiple regulatory layers essential to transcription factor activity
2020Open Access
A tetrapeptide class of biased analgesics from an Australian fungus targets the µ-opioid receptor
Proceedings of the National Academy of Sciences·2019· 37 citedOpen Access
R-propranolol is a small molecule inhibitor of the SOX18 transcription factor in a rare vascular syndrome and hemangioma
eLife·2019· 58 citedOpen Access
Author response: R-propranolol is a small molecule inhibitor of the SOX18 transcription factor in a rare vascular syndrome and hemangioma
2019· 1 citedOpen Access
Homodimerization regulates an endothelial specific signature of the SOX18 transcription factor
Nucleic Acids Research·2018· 32 citedOpen Access
Modulating transcription factor activity: Interfering with protein-protein interaction networks
Seminars in Cell and Developmental Biology·2018· 82 cited
Functional domain analysis of SOX18 transcription factor using a single-chain variable fragment-based approach
mAbs·2018· 8 citedOpen Access
Inhibitors of SOX 18 protein activity for treating angiogenesis- and/or lymphangiogenesis
Queensland's institutional digital repository (The University of Queensland)·2017
SOX18 transcription factor interactome: Protein‐Protein interaction a new road for anti‐cancer drug discovery
The FASEB Journal·2017
Small-Molecule Inhibitors of the SOX18 Transcription Factor
Cell chemical biology·2017· 55 citedOpen Access
Pharmacological targeting of the transcription factor SOX18 delays breast cancer in mice
eLife·2017· 71 citedOpen Access
Author response: Pharmacological targeting of the transcription factor SOX18 delays breast cancer in mice
2016Open Access
Author response: Pharmacological targeting of the transcription factor SOX18 delays breast cancer in mice
2016· 1 citedOpen Access
Pharmacological manipulation of transcription factor protein-protein interactions: opportunities and obstacles
Cell Regeneration·2015· 88 citedOpen Access
page 1 of 3Next →

Frequent Co-authors

Mathias François(20), Mehdi Moustaqil(13), Emma Sierecki(13), Robert J. Capon(13), Yann Gambin(13), Jeroen Overman(11), Philip Burcham(9), Johannes Zuegg(9), Peter Koopman(8), Angela A. Salim(8), Matthew A. Cooper(7), Sreeman Mamidyala(6), Emmanuelle Lesieur(6), Ralf Jauch(6), Alex McCann(6), Benjamin M. Hogan(5), Avril A. B. Robertson(5), Mark S. Butler(5), Kirill Alexandrov(5), Timothy L. Bailey(5)